Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Clin Cancer Res. 2017 May 23;23(17):5034–5043. doi: 10.1158/1078-0432.CCR-16-3016

Figure 4.

Figure 4

Neutralizing anti-GM-CSF antibodies. A: OS by presence of neutralizing GM-CSF antibody while on treatment. B: DFS by presence of neutralizing GM-CSF antibody while on treatment.